Press Release
Jaguar Health Reports First Quarter 2024 Financial Results
The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net Q1 2023 revenue of $2.0 million and increased approximately 4% versus net Q4 2023 revenue of $2.3 million Top line results expected to be imminent for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea Jaguar planning to begin commercial launch in Q3 2024 for Gelclair®, the company's third prescription product REMINDER: Jaguar to host investor webcast Tuesday, May 14th at 8:30 a.m. Eastern regarding Q1 2024 financials and company updates; Click here to register for webcast Read More
Press Release
Electrovaya Reports Second Quarter FY2024 Financial Results
$1.5 million in Adjusted EBITDA1, bringing the trailing 12 month Adjusted EBITDA1 to $5.8 million Revenue of $10.7 million and Gross Margins improved by 1240 basis points year over year to 35% Operating profit of $0.7 million with positive cash flow from operations for the quarter Read More
Press Release
Thousands Celebrate Lisa Vanderpump’s 7th Annual World Dog Day in West Hollywood
The Vanderpump Dog Foundation's World Dog Day, co-sponsored by the City of West Hollywood, is a huge success, with two thousand people and their dogs coming to celebrate dog rescue and support dog adoptions. Read More
Press Release
Black Book Survey Unveils Clearinghouse Transition Trends: 92% of Medical Practices Navigating Short-Term Fixes and Long-Term Vendor Solutions
Physician Claims Clients Endorse Four Companies That Are Excelling at Best Handling the New Customer Influx: Veradigm, Waystar, Experian, and Availity Read More
Press Release
